These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 8768733

  • 1. Role of cyclic GMP-inhibitable phosphodiesterase and nitric oxide in the beta adrenoceptor control of renin secretion.
    Chiu T, Reid IA.
    J Pharmacol Exp Ther; 1996 Aug; 278(2):793-9. PubMed ID: 8768733
    [Abstract] [Full Text] [Related]

  • 2. Stimulation of renin secretion by the phosphodiesterase IV inhibitor rolipram.
    Chiu N, Park I, Reid IA.
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1073-7. PubMed ID: 8786537
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of phosphodiesterase III with milrinone increases renin secretion in human subjects.
    Chiu YJ, Hu SH, Reid IA.
    J Pharmacol Exp Ther; 1999 Jul; 290(1):16-9. PubMed ID: 10381754
    [Abstract] [Full Text] [Related]

  • 4. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3.
    Beierwaltes WH.
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1376-81. PubMed ID: 16449359
    [Abstract] [Full Text] [Related]

  • 5. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK, Drew GM.
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [Abstract] [Full Text] [Related]

  • 6. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E, Belardi D, Tocchetti CG, Vahebi S, Cormaci G, Ketner EA, Moens AL, Champion HC, Kass DA.
    Circulation; 2007 Apr 24; 115(16):2159-67. PubMed ID: 17420342
    [Abstract] [Full Text] [Related]

  • 7. Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582.
    Pagani ED, Dundore RL, Bode DC, Bacon ER, Singh B, Lesher GY, Buchholz RA, Silver PJ.
    J Cardiovasc Pharmacol; 1994 Sep 24; 24(3):403-10. PubMed ID: 7528296
    [Abstract] [Full Text] [Related]

  • 8. Androgenic maintenance of the rat erectile response via a non-nitric-oxide-dependent pathway.
    Reilly CM, Lewis RW, Stopper VS, Mills TM.
    J Androl; 1997 Sep 24; 18(6):588-94. PubMed ID: 9432131
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y, Karmazyn M.
    Cardiovasc Res; 1996 Sep 24; 32(3):622-9. PubMed ID: 8881523
    [Abstract] [Full Text] [Related]

  • 10. Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).
    Bivalacqua TJ, Champion HC, Rajasekaran M, Sikka SC, Kadowitz PJ, Doherty PC, Hellstrom WJ.
    J Urol; 1999 Nov 24; 162(5):1848-55. PubMed ID: 10524946
    [Abstract] [Full Text] [Related]

  • 11. Involvement of endothelium-derived relaxing factor in the pressure control of renin secretion from isolated perfused kidney.
    Scholz H, Kurtz A.
    J Clin Invest; 1993 Mar 24; 91(3):1088-94. PubMed ID: 8383697
    [Abstract] [Full Text] [Related]

  • 12. Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed.
    McCulloch AI, Bottrill FE, Randall MD, Hiley CR.
    Br J Pharmacol; 1997 Apr 24; 120(8):1431-8. PubMed ID: 9113362
    [Abstract] [Full Text] [Related]

  • 13. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O, Gaudet E, Blanc J, Ponchon P, Elghozi JL.
    Arch Mal Coeur Vaiss; 1996 Aug 24; 89(8):1013-7. PubMed ID: 8949370
    [Abstract] [Full Text] [Related]

  • 14. Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation.
    Lugnier C, Komas N.
    Eur Heart J; 1993 Nov 24; 14 Suppl I():141-8. PubMed ID: 8293765
    [Abstract] [Full Text] [Related]

  • 15. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
    Banting JD, Friberg P, Adams MA.
    J Hypertens; 1996 Aug 24; 14(8):975-81. PubMed ID: 8884552
    [Abstract] [Full Text] [Related]

  • 16. Epimedium brevicornum Maxim extract relaxes rabbit corpus cavernosum through multitargets on nitric oxide/cyclic guanosine monophosphate signaling pathway.
    Chiu JH, Chen KK, Chien TM, Chiou WF, Chen CC, Wang JY, Lui WY, Wu CW.
    Int J Impot Res; 2006 Aug 24; 18(4):335-42. PubMed ID: 16395327
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-1 beta induces the formation of nitric oxide in isolated juxtaglomerular cells: influence on renin secretion.
    Galle J, Schini VB, Stunz P, Wanner C, Schollmeyer P.
    Nephrol Dial Transplant; 1995 Aug 24; 10(2):191-7. PubMed ID: 7538649
    [Abstract] [Full Text] [Related]

  • 18. Myocardial effects of cyclic AMP phosphodiesterase inhibition are dampened in thyroxine-induced cardiac hypertrophy.
    Straznicka M, Leone RJ, Scholz PM, Weiss HR.
    J Surg Res; 1998 Apr 24; 76(1):61-6. PubMed ID: 9695741
    [Abstract] [Full Text] [Related]

  • 19. Role of nitric oxide in the renin and heart rate responses to beta-adrenergic stimulation.
    Reid IA, Bui H, Chou L.
    Hypertension; 1994 Jan 24; 23(1 Suppl):I49-53. PubMed ID: 8282375
    [Abstract] [Full Text] [Related]

  • 20. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
    Hu L, Sealey JE, Chen R, Zhou Y, Merali C, Shi Y, Laragh JH, Catanzaro DF.
    Am J Hypertens; 2004 May 24; 17(5 Pt 1):395-403. PubMed ID: 15110897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.